A股異動 | 泉峯汽車(603982.SH)續漲6.5% 中期業績大增疊加獲券商看好
格隆匯8月24日丨泉峯汽車(603982.SH)股價繼續走強,盤中最高見20.06元創7個月新高,現報19.43元,漲幅6.5%,最新總市值39.1億;近5個交易日累計上漲約24%。公司19日公吿稱,今年上半年營業收入約8.06億元,同比增長57.13%;歸屬於上市公司股東的淨利潤約7836.44萬元,同比增長266.39%。海通證券指,參考可比公司估值水平同時考慮到公司具備較高成長性,給予其2021年26-28倍PE,對應合理價值區間23.14-24.92元,維持“優於大市”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.